These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2582725)

  • 1. Sympathetic vasoconstriction as a mechanism of action of ouabain in forearm arterioles of hypertensive patients.
    Pedrinelli R; Taddei S; Salvetti A
    Clin Sci (Lond); 1989 Nov; 77(5):541-5. PubMed ID: 2582725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ouabain vasoconstricts human forearm arterioles through alpha-adrenergic stimulation.
    Taddei S; Salvetti A; Pedrinelli R
    J Hypertens Suppl; 1988 Dec; 6(4):S357-9. PubMed ID: 2853745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of sympathetic-mediated forearm vasoconstriction after alpha-blockade in hypertensive patients.
    Taddei S; Salvetti A; Pedrinelli R
    Circulation; 1989 Sep; 80(3):485-90. PubMed ID: 2569947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin blunts sympathetic vasoconstriction through the alpha 2-adrenergic pathway in humans.
    Lembo G; Iaccarino G; Rendina V; Volpe M; Trimarco B
    Hypertension; 1994 Oct; 24(4):429-38. PubMed ID: 7916334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ouabain-induced elevation in forearm vascular resistance, calcium entry and alpha-adrenoceptor blockade, and release and removal of noradrenaline.
    Schulte KL; van Gemmeren D; Thiede HM; Meyer-Sabellek W; Gotzen R; Distler A
    J Hypertens Suppl; 1987 Dec; 5(5):S215-8. PubMed ID: 2895170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forearm vasoconstrictor response to ouabain: studies in patients with mild and moderate essential hypertension.
    Hulthén UL; Bolli P; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S75-81. PubMed ID: 6204162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contracting human skeletal muscle maintains the ability to blunt α1 -adrenergic vasoconstriction during KIR channel and Na(+) /K(+) -ATPase inhibition.
    Crecelius AR; Kirby BS; Hearon CM; Luckasen GJ; Larson DG; Dinenno FA
    J Physiol; 2015 Jun; 593(12):2735-51. PubMed ID: 25893955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the arteriolar smooth muscle NA+ -K+-pump induces an enhanced vasoconstriction in borderline but not in established essential hypertension.
    Hulthén UL; Bolli P; Kiowski W; Bühler FR
    Gen Pharmacol; 1983; 14(1):193-6. PubMed ID: 6826033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular responses to ouabain and norepinephrine in low and normal renin hypertension.
    Pedrinelli R; Taddei S; Graziadei L; Salvetti A
    Hypertension; 1986 Sep; 8(9):786-92. PubMed ID: 3017854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forearm vasoconstriction to endothelin-1 is impaired, but constriction to sarafotoxin 6c and vasodilatation to BQ-123 unaltered, in patients with essential hypertension.
    Ferro CJ; Haynes WG; Hand MF; Webb DJ
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():53S-58S. PubMed ID: 12193054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intra-arterial endothelin on resting blood flow and sympathetically mediated vasoconstriction in the forearm of man.
    Cockcroft JR; Clarke JG; Webb DJ
    Br J Clin Pharmacol; 1991 May; 31(5):521-4. PubMed ID: 1888618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forearm blood flow responses to neuropeptide Y, noradrenaline and adenosine 5'-triphosphate in hypertensive and normotensive subjects.
    Nilsson T; Hrafnkelsdóttir T; Edvinsson L; Jern S; Erlinge D; Wall U
    Blood Press; 2000; 9(2-3):126-31. PubMed ID: 10855736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man.
    Clarke J; Benjamin N; Larkin S; Webb D; Maseri A; Davies G
    Circulation; 1991 Mar; 83(3):774-7. PubMed ID: 1999028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma noradrenaline concentration and alpha-adrenoceptor-mediated vasoconstriction in normotensive and hypertensive man.
    Kiowski W; Bühler FR; van Brummelen P; Amann FW
    Clin Sci (Lond); 1981 May; 60(5):483-9. PubMed ID: 7249534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective AT1 receptor antagonism enhances sympathetically mediated vasoconstriction in man.
    Lyons D; Jackson SH; Swift CG
    Clin Pharmacol Ther; 2007 Jan; 81(1):83-7. PubMed ID: 17186003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forearm vasoconstriction in response to noradrenaline and NG-monomethyl-L-arginine in essential hypertension.
    Kneale BJ; Chowienczyk PJ; Brett SE; Cockcroft JR; Ritter JM
    Clin Sci (Lond); 1999 Sep; 97(3):277-82. PubMed ID: 10464052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in the forearm: differences between normotensive and hypertensive subjects.
    Jie K; van Brummelen P; Vermey P; Timmermans PB; van Zwieten PA
    J Hypertens Suppl; 1985 Dec; 3(3):S89-91. PubMed ID: 2908822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for nitric oxide-mediated sympathetic forearm vasodiolatation in humans.
    Dietz NM; Engelke KA; Samuel TT; Fix RT; Joyner MJ
    J Physiol; 1997 Jan; 498 ( Pt 2)(Pt 2):531-40. PubMed ID: 9032700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for functional alpha 2-adrenoceptors on vascular sympathetic nerve endings in the human forearm.
    Grossman E; Chang PC; Hoffman A; Tamrat M; Goldstein DS
    Circ Res; 1991 Oct; 69(4):887-97. PubMed ID: 1657439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the vasoconstrictor action of sympathomimetic agents by bretylium tosylate and tranylcypromine in man.
    Frewin DB; Jellett LB; Whelan RF
    Br J Pharmacol; 1969 Jul; 36(3):602-10. PubMed ID: 5789812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.